Akebia Ther Net Worth
Akebia Ther Net Worth Breakdown | AKBA |
Akebia Ther Net Worth Analysis
Akebia Ther's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Akebia Ther's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Akebia Ther's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Akebia Ther's net worth analysis. One common approach is to calculate Akebia Ther's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Akebia Ther's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Akebia Ther's net worth. This approach calculates the present value of Akebia Ther's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Akebia Ther's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Akebia Ther's net worth. This involves comparing Akebia Ther's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Akebia Ther's net worth relative to its peers.
Enterprise Value |
|
To determine if Akebia Ther is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Akebia Ther's net worth research are outlined below:
| Akebia Ther appears to be risky and price may revert if volatility continues | |
| Akebia Ther has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 194.62 M. Net Loss for the year was (51.92 M) with profit before overhead, payroll, taxes, and interest of 140.04 M. | |
| Akebia Ther currently holds about 143.89 M in cash with (23.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.78. | |
| Akebia Ther has a poor financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference |
Akebia Ther uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Akebia Ther. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Akebia Ther's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Akebia Ther's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Akebia Ther is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akebia Ther backward and forwards among themselves. Akebia Ther's institutional investor refers to the entity that pools money to purchase Akebia Ther's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Federated Hermes Inc | 2024-09-30 | 868 K | Fmr Inc | 2024-09-30 | 682 K | Bank Of New York Mellon Corp | 2024-06-30 | 604.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 568.7 K | Nuveen Asset Management, Llc | 2024-06-30 | 380.5 K | Goldman Sachs Group Inc | 2024-06-30 | 348.9 K | Susquehanna International Group, Llp | 2024-06-30 | 248.8 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 247.1 K | Rhumbline Advisers | 2024-06-30 | 247.1 K | Blackrock Inc | 2024-06-30 | 11.6 M | Vanguard Group Inc | 2024-09-30 | 10.1 M |
Follow Akebia Ther's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 449.45 M.Market Cap |
|
Project Akebia Ther's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.35) | (0.37) | |
| Return On Capital Employed | (0.33) | (0.34) | |
| Return On Assets | (0.21) | (0.23) | |
| Return On Equity | 1.70 | 1.78 |
When accessing Akebia Ther's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Akebia Ther's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Akebia Ther's profitability and make more informed investment decisions.
Please note, the presentation of Akebia Ther's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akebia Ther's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Akebia Ther's management manipulating its earnings.
Evaluate Akebia Ther's management efficiency
Akebia Ther has return on total asset (ROA) of (0.0937) % which means that it has lost $0.0937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.5345) %, meaning that it created substantial loss on money invested by shareholders. Akebia Ther's management efficiency ratios could be used to measure how well Akebia Ther manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 1.78, whereas Return On Tangible Assets are forecasted to decline to (0.37). At present, Akebia Ther's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 182 M, whereas Other Current Assets are forecasted to decline to about 12.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.16) | (0.15) | |
| Tangible Book Value Per Share | (0.67) | (0.64) | |
| Enterprise Value Over EBITDA | (42.77) | (40.63) | |
| Price Book Value Ratio | (7.60) | (7.22) | |
| Enterprise Value Multiple | (42.77) | (40.63) | |
| Price Fair Value | (7.60) | (7.22) | |
| Enterprise Value | 293.7 M | 394.5 M |
Akebia Ther's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Enterprise Value Revenue 2.7314 | Revenue 169.9 M | Quarterly Revenue Growth (0.11) | Revenue Per Share 0.834 | Return On Equity (5.53) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akebia Ther insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akebia Ther's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Akebia Ther insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Akebia Ther Corporate Filings
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 3rd of September 2024 Other Reports | ViewVerify | |
F4 | 2nd of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Akebia Ther Earnings per Share Projection vs Actual
Akebia Ther Corporate Management
| Nicole Hadas | Sr. VP, General Counsel and Secretary | Profile | |
| Kristie Bolieau | VP Controller | Profile | |
| Mercedes Carrasco | Director Communications | Profile | |
| David Spellman | CFO VP | Profile | |
| Tracey Vetterick | Vice Administration | Profile | |
| Thierry Bilbault | VP Devel | Profile |
Already Invested in Akebia Ther?
The danger of trading Akebia Ther is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Akebia Ther is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Akebia Ther. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Akebia Ther is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akebia Ther. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.22) | Revenue Per Share 0.834 | Quarterly Revenue Growth (0.11) | Return On Assets (0.09) | Return On Equity (5.53) |
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.